Express Scripts’ new Cardiovascular Care ValueSM program expands on our SafeGuardRx® Cholesterol Care ValueSM program to holistically tackle the clinical and financial...
The market for purchasing drugs can be complex, but with MAC pricing, multi-sourced generic medications are kept as affordable as possible in the U.S.
Biosimilars have the potential to significantly reduce treatment costs. We take a look at the growing biosimilar pathway.
We're encouraged that Gilead Sciences is taking meaningful action to bring prices down for cash-paying customers.
Since 2008, brand medications have risen in price an average 232%. We need to work with pharma and the government for common-sense legislation and regulatory changes.